Owlstone Medical, one of the UK’s most promising medtech start-ups, is continuing its expansion into pharma partnering via a new deal with AstraZeneca.
A series of cancer diagnosis 'one-stop shops' is being rolled out across England, with digital health technology playing an important role in hastening diagnosis.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
